GC Wealth Management RIA’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GC Wealth Management RIA's REGN Position: Q2 2026 in Review
GC Wealth Management RIA reduced its Regeneron Pharmaceuticals (REGN) stake by 26% in Q2 2026, selling an estimated $403K and leaving 1,705 shares worth $1.06M. The position accounts for 0.06% of the portfolio, ranked #218.
GC Wealth Management RIA first reported a position in REGN in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.77M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- GC Wealth Management RIA held 1,705 shares of Regeneron Pharmaceuticals worth $1.06M as of Q2 2026.
- GC Wealth Management RIA sold 592 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $403K.
- Regeneron Pharmaceuticals made up 0.06% of GC Wealth Management RIA's portfolio in Q2 2026, its #218 holding.
- GC Wealth Management RIA first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
- GC Wealth Management RIA's Regeneron Pharmaceuticals position peaked at $1.77M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.